Form 4 for TTRX Turn Therapeutics Inc.
Accepted 2025-10-23 00:00:00 ET · period of report 2025-10-23 · accession 0001104659-25-101923 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-23 | 2025-10-23 | TTRX | GOLDEN ARTHUR F | Dir | P - Purchase | $4.95 | +20.2K | 30.2K | +202% | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-23 | P | A | 20,202 | $4.95 | 30,202 | D | — | — | (F1) Certain of the securities reported in Column 5 of Table I are restricted stock units ("RSUs") granted under the Issuer's 2025 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and the reporting person's continuous service through the vesting date. |